Shan-ju Hsu

Title: Innovations by Shan-ju Hsu in Cancer Treatment

Introduction

Shan-ju Hsu is a notable inventor based in Tainan, Taiwan. He has made significant contributions to the field of cancer treatment, particularly in enhancing the efficacy of chemotherapeutic drugs. His work focuses on improving the treatment of pancreatic cancer, a disease known for its challenging prognosis.

Latest Patents

Shan-ju Hsu holds a patent titled "Method for improving an effect of chemotherapeutic drug of gemcitabine on inhibiting pancreatic cancer and improving side effect of chemotherapeutic drug of Gemcitabine." This innovative probiotic composition aims to enhance the effectiveness of the chemotherapeutic drug Gemcitabine in treating pancreatic cancer. The composition includes GMNL-133 and GMNL-89, both of which have been deposited in the China Center for Type Culture Collection under specific accession numbers. This patent represents a significant advancement in the fight against pancreatic cancer.

Career Highlights

Shan-ju Hsu is associated with Genmont Biotech Inc., where he continues to develop innovative solutions for cancer treatment. His work is characterized by a commitment to improving patient outcomes through scientific research and innovation.

Collaborations

Shan-ju Hsu collaborates with notable colleagues, including Wan-Hua Tsai and I-ling Hsu. Their combined expertise contributes to the advancement of research in the field of biotechnology and cancer treatment.

Conclusion

Shan-ju Hsu's contributions to cancer treatment through his innovative patent demonstrate his dedication to improving therapeutic options for patients. His work exemplifies the potential of biotechnology in addressing complex health challenges.